Open Access
Table 5.
Resolution of clinical signs and symptoms during the assessment period of 90 days.
| Day | Clinical sign | Group 1 (Imidacloprid/moxidectin) |
Group 2 (afoxolaner) |
|---|---|---|---|
| Number of dogs (%) | Number of dogs (%) | ||
| −2/−1 | Casts | 1/8 (12.5) | 1/8 (12.5) |
| Crusts | 6/8 (75) | 7/8 (87.5) | |
| Scales | 4/8 (50) | 1/8 (12.5) | |
| Erythematous papules | 1/8 (12.5) | 1/8 (12.5) | |
| 28 | Casts | 1/8 (12.5) | 1/8 (12.5) |
| Crusts | 7/8 (87.5) | 4/8 (50) | |
| Scales | 5/8 (62.5) | 1/8 (12.5) | |
| Erythematous papules | 0/8 (0) | 0/8 (0) | |
| 56 | Casts | 0/8 (0) | 0/8 (0) |
| Crusts | 5/8 (62.5) | 2/8 (25) | |
| Scales | 4/8 (50) | 2/8 (25) | |
| Erythematous papules | 1/8 (12.5) | 0/8 (0) | |
| 84 | Casts | 0/8 (0) | 0/8 (0) |
| Crusts | 3/8 (37.5) | 2/8 (25) | |
| Scales | 4/8 (50) | 2/8 (25) | |
| Erythematous papules | 0/8 (0) | 0/8 (0) |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.